If you've got $1,000 ready to invest, which won't be needed for bill or emergencies, the following five stocks would make for perfect buys for the fourth quarter. While I'm generally not a fan of chasing the coronavirus stocks after they've catapulted into the stratosphere, clinical-stage biotech stock Novavax (NASDAQ: NVAX) is the rare exception. The company's coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373, led to an 89.7% vaccine efficacy (VE) in a large-scale trial in the U.K. earlier this year, and it produced a nearly identical 90.4% VE in a large-scale trial in the U.S. and Mexico in June.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
- Motley Fool
This week, some Americans eager for more stimulus money will get their wish. Payments will be deposited into bank accounts on Oct. 15, 2021 for one of the key types of financial assistance made available by the American Rescue Plan Act. The payments that are being delivered on Oct. 15 are going to eligible parents and will come as a result of the expansion of the Child Tax Credit authorized by the American Rescue Plan Act.
- Business Insider
Creators who are a part of YouTube's Partner Program can monetize their YouTube videos with ads, with some receiving six-figure monthly paychecks.
Advisory committee supports authorizing a third, smaller dose of Covid vaccine for people aged 18 to 64 at high risk of severe disease, or whose work puts them at higher risk.
The broker started research coverage of “top four” Bitcoin mining stocks with a positive view on the sector for the near term.
- Motley Fool
Being a great investor sometimes involves making assumptions about the future of technology, so watch these two companies closely.
- Business Insider
Scientists gave J&J vaccine recipients different booster shots in a highly anticipated trial, and found they got a much better immune response with Moderna and Pfizer
A J&J booster gave a 4-fold jump in antibodies, but those who got Moderna or Pfizer boosters in the mix-and-match trial saw up to 76-fold increases.
- Motley Fool
In August last year, an anonymous person or entity known as Ryoshi created SHIB as a token on Ethereum's ERC-20 blockchain. Nowadays, anyone can create a token and launch it on an existing blockchain. In fact, there's even a website -- cointool.app -- that allows users to set a token name, symbol, initial supply, add-ons (token burning, minting, etc.), and blockchain (such as ERC-20) for launch.
Bitcoin has been on an uptick lately, but other cryptos are also worth keeping an eye on in the fourth quarter, many experts are saying. Explore: US Leads World Bitcoin Mining, Following China Mining...
Vietnamese automaker Vinfast will begin taking pre-orders in the U.S. market for its VF e35 and e36 electric SUVs in the first half of 2022 and expects to begin delivering them by the end of the year, global Chief Executive Michael Lohscheller said. "It's still early to make any sales predictions, but VinFast will unveil two of our latest EV models, which are VF e35 and VF e36, at the 2021 Los Angeles auto show this November, thus marking our official introduction to the American market," he said in an email to Reuters. The company expects to begin delivering its first EVs in Vietnam starting in December, said Lohscheller, a former Volkswagen and Opel executive who was named to his position at Vinfast in July.
Alaska state Sen. Lora Reinbold said on Facebook she was "taking lots of vitamins" in the wake of her positive diagnosis
- Miami Herald
The booster would be half the dose of the first two shots.
"The hardest part was knowing that there was something in there, growing," Kasie Hunt tells PEOPLE exclusively
- USA TODAY
Podcast icon Joe Rogan said he isn't anti-vaccine and that he attempted to get the COVID-19 vaccination three months ago but missed the appointment.
These stocks have dividend yields as high as 5.91%, and the companies never cut dividends after oil prices began their long decline in 2014.
- Rolling Stone
Hint: A lot more likely
One of several reasons I have for betting that the fund will outperform the S&P 500 (SPX) is the historical outperformance of so-called sin stocks. Consider the results of a study conducted by Elroy Dimson, a finance professor at Cambridge University, Paul Marsh, a finance professor at the London Business School, and Mike Staunton, director of that institution’s London Share Price Database. The chart below shows what they found for alcohol and tobacco stocks’ performance over the past 120 years.
- FX Empire
A buying spike above 45 would mark a highly bullish event, opening the door to a test of 2007’s all-time high.
The Reddit crowd has found a new tactic in the war against Wall Street: cutting brokers out altogether
Meme stocks closed mixed on Thursday, but retail investors appear to be finally jumping in with the gusto on so-called direct registration.
- Insider Monkey
In this article, we discuss the 11 best value stocks to buy according to Warren Buffett. You can skip our detailed analysis of Buffett’s investment strategies and go directly to read the 5 Best Value Stocks To Buy According To Warren Buffett. Warren Buffett does not need any introduction in the investment world. He is […]
Stuck for fresh investing inspiration? You’re not alone. Plenty of uncertainty lingers on Wall Street as we head into 2022. Inflation is up, the job market remains stuck in an ugly combination of stubborn unemployment and record-high levels of job openings, all while Congress and the Biden Administration are looking less and less capable of passing a set of aggressive spending plans. Writing from JPMorgan, global market strategist Marko Kolanovic acknowledges the headwinds but thinks there are p